How This CRISPR Biotech Could Make Investors Rich
A look at a biotech company that represents a solid trend in the industry. Source: BioSpace
A look at a biotech company that represents a solid trend in the industry. Source: BioSpace
It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases. Source: BioSpace
A look at a small-cap biotech company that investors should consider. Source: BioSpace
Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace
The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders and management team, as well as original investors Oak Investment Partners and J.H. Whitney. Source:…
Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests. Source: BioSpace
Shire filed its first submission to the FDA for its new plasma manufacturing site in Covington, Georgia. Source: BioSpace
Novartis announced today that the FDA approved the inclusion of Treatment-free Remission data in the Tasigna U.S. product label. Source: BioSpace
In a result that could have far-reaching implications for brand-name drug manufacturers, the California Supreme Court unanimously ruled Novartis can be held liable for injuries caused by generics of its…
United Therapeutics agreed to pay $210 million to resolve Justice Department claims that the drugmaker collaborated with charity Caring Voice Coalition (CVC) to boost sales of United’s pulmonary arterial hypertension…